Education
About Us
Working with TipRanks
Follow Us
enVVeno Medical (NVNO)
NASDAQ:NVNO
NVNO Stock Chart & Stats
$0.39
-$0.06(-1.92%)
At close: 4:00 PM EST
$0.39
-$0.06(-1.92%)
Day’s Range― - ―
52-Week Range$0.30 - $5.62
Previous CloseN/A
Volume33.14K
Average Volume (3M)589.93K
Market Cap
$13.14M
Enterprise Value$46.94M
Total Cash (Recent Filing)$30.95M
Total Debt (Recent Filing)$791.00K
Price to Earnings (P/E)―
Beta1.34
Next Earnings
Feb 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding20,216,175
10 Day Avg. Volume395,892
30 Day Avg. Volume589,933
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)1.23
Price to Sales (P/S)0.00
P/FCF Ratio-3.07
Enterprise Value/Market Cap3.57
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-95.03
Enterprise Value/Ebitda-2.19
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
enVVeno Medical News
NVNO FAQ
What was enVVeno Medical’s price range in the past 12 months?
enVVeno Medical lowest stock price was $0.30 and its highest was $5.62 in the past 12 months.
What is enVVeno Medical’s market cap?
enVVeno Medical’s market cap is $13.14M.
When is enVVeno Medical’s upcoming earnings report date?
enVVeno Medical’s upcoming earnings report date is Feb 26, 2026 which is in 83 days.
How were enVVeno Medical’s earnings last quarter?
enVVeno Medical released its earnings results on Nov 06, 2025. The company reported -$0.225 earnings per share for the quarter, beating the consensus estimate of -$0.3 by $0.075.
Is enVVeno Medical overvalued?
According to Wall Street analysts enVVeno Medical’s price is currently Overvalued.
Does enVVeno Medical pay dividends?
enVVeno Medical does not currently pay dividends.
What is enVVeno Medical’s EPS estimate?
enVVeno Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does enVVeno Medical have?
enVVeno Medical has 20,216,175 shares outstanding.
What happened to enVVeno Medical’s price movement after its last earnings report?
enVVeno Medical reported an EPS of -$0.225 in its last earnings report, beating expectations of -$0.3. Following the earnings report the stock price went down -2.941%.
Which hedge fund is a major shareholder of enVVeno Medical?
Currently, no hedge funds are holding shares in NVNO
Company Description
enVVeno Medical
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Technical Analysis
Ownership Overview
2.27% Insiders
4.28% Mutual Funds
18.72% Other Institutional Investors
70.72% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---